Liu Ming, Lu Youyi, Sun Fengze, Li Yongwei, Wu Jitao, Zou Qingsong
Department of Urology, Yantai Yuhuangding Hospital, Qingdao University, No. 20 East Yuhuangding Road, Yantai, 264000, Shandong, China.
Second Clinical Medical College, Binzhou Medical University, Yantai, 264003, Shandong, China.
Mol Neurobiol. 2025 Jun;62(6):7330-7344. doi: 10.1007/s12035-025-04704-z. Epub 2025 Jan 30.
Stress urinary incontinence (SUI) currently lacks effective treatment options, and the restoration of neurological function remains a major challenge, with unmet clinical needs. Research has indicated that adipose-derived stem cells (ADSCs) can be induced to differentiate into neural-induced adipose-derived stem cells (NI-ADSCs) under specific inductive conditions, exhibiting excellent neuroregenerative capabilities. ADSCs were obtained from female SD rats and induced into NI-ADSCs. In vitro, NI-ADSCs were co-cultured with Schwann cells (SCs) to investigate their effects on SC proliferation and repair phenotype transition and further explore its underlying mechanism. In vivo, a rat model of SUI was established using a bilateral pudendal nerve transection method. NI-ADSCs were injected into the urethral sphincter to evaluate their effects on urodynamics, muscle angiogenesis, and neural repair in SUI rats, while also exploring the mechanisms of neural repair. This study used EGF, FGF, and B27 to induce ADSCs into NI-ADSCs expressing neural induction markers (MAP, Nestin, and PAX6). In vitro experiments found no significant difference in the proliferation of L6 and RSC96 between NI-ADSCs and ADSCs (p > 0.05). However, when co-cultured with NI-ADSCs, SCs showed upregulated expression of repair-related phenotypic markers (BDNF, GDNF, and GFAP). In this phenotypic transformation process, the expression of Notch-related pathway proteins (Notch1, NICD, and Hes1) was increased, and the use of DAPT (a Notch pathway inhibitor) could suppress the SC repair phenotype transformation. In vivo, experiments revealed that intraurethral injection of NI-ADSCs significantly promoted the expression of neural marker (S100β) and demyelination markers (GFAP) and urodynamic recovery in SUI rats, while DAPT inhibited its neural repair effect. In summary, our study demonstrates that NI-ADSCs can promote nerve regeneration by promoting and maintaining the repair-related phenotype of SCs. The underlying mechanism may be related to the activation of the Notch signaling pathway.
压力性尿失禁(SUI)目前缺乏有效的治疗选择,神经功能的恢复仍然是一项重大挑战,存在未满足的临床需求。研究表明,脂肪来源干细胞(ADSCs)在特定诱导条件下可被诱导分化为神经诱导脂肪来源干细胞(NI-ADSCs),具有出色的神经再生能力。从雌性SD大鼠获取ADSCs并诱导为NI-ADSCs。在体外,将NI-ADSCs与雪旺细胞(SCs)共培养,以研究其对SC增殖和修复表型转变的影响,并进一步探索其潜在机制。在体内,采用双侧阴部神经横断法建立SUI大鼠模型。将NI-ADSCs注入尿道括约肌,以评估其对SUI大鼠尿动力学、肌肉血管生成和神经修复的影响,同时也探索神经修复机制。本研究使用表皮生长因子(EGF)、成纤维细胞生长因子(FGF)和B27将ADSCs诱导为表达神经诱导标志物(微管相关蛋白(MAP)、巢蛋白和配对盒基因6(PAX6))的NI-ADSCs。体外实验发现,NI-ADSCs与ADSCs之间,L6和RSC96细胞的增殖无显著差异(p>0.05)。然而,当与NI-ADSCs共培养时,SCs显示出修复相关表型标志物(脑源性神经营养因子(BDNF)、胶质细胞源性神经营养因子(GDNF)和胶质纤维酸性蛋白(GFAP))的表达上调。在这种表型转化过程中,Notch相关通路蛋白(Notch1、Notch胞内结构域(NICD)和毛状分裂增强子1(Hes1))的表达增加,使用二氮杂环辛烷(DAPT,一种Notch通路抑制剂)可抑制SCs修复表型转化。在体内,实验表明尿道内注射NI-ADSCs可显著促进SUI大鼠神经标志物(S100β)和脱髓鞘标志物(GFAP)的表达以及尿动力学恢复,而DAPT可抑制其神经修复作用。总之,我们的研究表明,NI-ADSCs可通过促进和维持SCs的修复相关表型来促进神经再生。其潜在机制可能与Notch信号通路的激活有关。